Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials.

Mohammad Shehab,Fatema Alrashed,Afrah Alkazemi, Peter L Lakatos,Talat Bessissow

Expert review of gastroenterology & hepatology（2023）

引用 2|浏览4

暂无评分

摘要

The use of biologic therapies and small molecules among adult patients with IBD had no significant impact on the risk of MACEs during induction and maintenance period of RCTs. Real world data is warranted to assess long-term risks.

查看译文

关键词

Crohn’s disease,biologics: small molecules,inflammatory bowel disease,major adverse cardiovascular events,ulcerative colitis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要